Search research articles
Contact Us
Filters
Showing results (101-110 of 109) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 109 results.
Nature Communications
|
December 8, 2022
Author Correction: Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19
Nicolas de Prost, Etienne Audureau, Nicholas Heming, et al.
Annals of Intensive Care
|
June 14, 2024
Correction: COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants
Pierre Bay, Etienne Audureau, Sébastien Préau, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
March 30, 2021
Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients
Christelle Vauloup-Fellous, Sarah Maylin, Claire Périllaud-Dubois, et al.
Annals of Intensive Care
|
April 24, 2024
COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants
Pierre Bay, Etienne Audureau, Sébastien Préau, et al.
The Lancet. Microbe
|
June 2, 2026
Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in France
Slim Fourati, Alawiya Reslan, Jérôme Bourret, et al.
Science Immunology
|
July 20, 2022
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
Paul Bastard, Sara E Vazquez, Jamin Liu, et al.
Research Square
|
January 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies
Jeremy Manry, Paul Bastard, Adrian Gervais, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 16, 2022
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Jérémy Manry, Paul Bastard, Adrian Gervais, et al.
Science Immunology
|
August 20, 2021
Autoantibodies neutralizing type I IFNs are present in <b>~</b>4% of uninfected individuals over 70 years old and account for <b>~</b>20% of COVID-19 deaths
Paul Bastard, Adrian Gervais, Tom Le Voyer, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 109) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 109 results.
Nature Communications
|
December 8, 2022
Author Correction: Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19
Nicolas de Prost, Etienne Audureau, Nicholas Heming, et al.
Annals of Intensive Care
|
June 14, 2024
Correction: COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants
Pierre Bay, Etienne Audureau, Sébastien Préau, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
March 30, 2021
Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients
Christelle Vauloup-Fellous, Sarah Maylin, Claire Périllaud-Dubois, et al.
Annals of Intensive Care
|
April 24, 2024
COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants
Pierre Bay, Etienne Audureau, Sébastien Préau, et al.
The Lancet. Microbe
|
June 2, 2026
Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in France
Slim Fourati, Alawiya Reslan, Jérôme Bourret, et al.
Science Immunology
|
July 20, 2022
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
Paul Bastard, Sara E Vazquez, Jamin Liu, et al.
Research Square
|
January 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies
Jeremy Manry, Paul Bastard, Adrian Gervais, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 16, 2022
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Jérémy Manry, Paul Bastard, Adrian Gervais, et al.
Science Immunology
|
August 20, 2021
Autoantibodies neutralizing type I IFNs are present in <b>~</b>4% of uninfected individuals over 70 years old and account for <b>~</b>20% of COVID-19 deaths
Paul Bastard, Adrian Gervais, Tom Le Voyer, et al.
Page
of 11